FGB levels significantly differ in the urinary tracts of patients with bladder cancer compared with those of controls and are elevated in bladder cancer tissue compared with those of morphologically normal tissue, indicating that FGB is a potential biomarker for bladder cancer (29). Here, FGB is linked to urinary bladder cancer.